| Phase I |
2
|
(3%)
|
| Phase II |
13
|
(22%)
|
| Phase III |
34
|
(58%)
|
| Phase IV |
7
|
(12%)
|
| Observational study |
3
|
(5%)
|
| Total |
59
|
(100%)
|
| Statistical support in the development of the protocol |
4
|
(7%)
|
| Data entry |
13
|
(22%)
|
| Data management |
13
|
(22%)
|
| Statistical analysis planning |
54
|
(91%)
|
| Analysis/ programming |
58
|
(98%)
|
| Statistical support in regulatory submission |
5
|
(8%)
|
| All studies |
59
|
(100%)
|
Currently ongoing studies involve the following
Malaria, COPD, immuno-suppression after transplantation, lung cancer, rheumatoid arthritis, asthma,
pancreatic enzyme supplementation, medical devices, diabetes, hypertension, sepsis, psoriasis, HIV,
cystic fibrosis, hepatitis C, uveitis, and others.
|
